{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:54:55Z","timestamp":1786791295473,"version":"build-2736575974"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.1493","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T22:33:22Z","timestamp":1536014002000},"page":"e181493","source":"Crossref","is-referenced-by-count":86,"title":["Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity"],"prefix":"10.1001","volume":"1","author":[{"given":"Andres","family":"Cardenas","sequence":"first","affiliation":[{"name":"Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russ","family":"Hauser","sequence":"additional","affiliation":[{"name":"Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane R.","family":"Gold","sequence":"additional","affiliation":[{"name":"Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Channing Division of Network Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken P.","family":"Kleinman","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, University of Massachusetts\u2013Amherst School of Public Health and Health Sciences, Amherst"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Hivert","sequence":"additional","affiliation":[{"name":"Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, Massachusetts"},{"name":"Diabetes Unit, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby F.","family":"Fleisch","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetes, Maine Medical Center, Portland"},{"name":"Center for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-I D.","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia M.","family":"Calafat","sequence":"additional","affiliation":[{"name":"Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Webster","sequence":"additional","affiliation":[{"name":"Department of Environmental Health, Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Horton","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Oken","sequence":"additional","affiliation":[{"name":"Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"key":"zoi180096r1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.envint.2013.05.009","article-title":"Cumulative health risk assessment of 17 perfluoroalkylated and polyfluoroalkylated substances (PFASs) in the Swedish population.","volume":"59","author":"Borg","year":"2013","journal-title":"Environ Int"},{"issue":"7","key":"zoi180096r2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1021\/es062686m","article-title":"Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition Examination Survey (NHANES).","volume":"41","author":"Calafat","year":"2007","journal-title":"Environ Sci Technol"},{"issue":"11","key":"zoi180096r3","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1289\/ehp.10598","article-title":"Polyfluoroalkyl chemicals in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.","volume":"115","author":"Calafat","year":"2007","journal-title":"Environ Health Perspect"},{"issue":"11","key":"zoi180096r4","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1021\/es052580b","article-title":"Biological monitoring of polyfluoroalkyl substances: a review.","volume":"40","author":"Houde","year":"2006","journal-title":"Environ Sci Technol"},{"issue":"11","key":"zoi180096r5","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1021\/es900272u","article-title":"Polyfluoroalkyl chemicals in pooled blood serum from infants, children, and adults in Australia.","volume":"43","author":"Toms","year":"2009","journal-title":"Environ Sci Technol"},{"issue":"6","key":"zoi180096r6","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ijheh.2017.06.005","article-title":"Serum concentrations of per- and poly-fluoroalkyl substances and factors associated with exposure in the general adult population in South Korea.","volume":"220","author":"Lee","year":"2017","journal-title":"Int J Hyg Environ Health"},{"issue":"19","key":"zoi180096r7","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.1021\/es1043613","article-title":"Trends in exposure to polyfluoroalkyl chemicals in the US population: 1999-2008.","volume":"45","author":"Kato","year":"2011","journal-title":"Environ Sci Technol"},{"issue":"7","key":"zoi180096r8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1021\/es001834k","article-title":"Global distribution of perfluorooctane sulfonate in wildlife.","volume":"35","author":"Giesy","year":"2001","journal-title":"Environ Sci Technol"},{"issue":"17","key":"zoi180096r9","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1021\/es9010465","article-title":"Polyfluorinated compounds in the atmosphere of the Atlantic and Southern Oceans: evidence for a global distribution.","volume":"43","author":"Dreyer","year":"2009","journal-title":"Environ Sci Technol"},{"issue":"19","key":"zoi180096r11","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.1021\/es200171y","article-title":"Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans?","volume":"45","author":"D\u2019eon","year":"2011","journal-title":"Environ Sci Technol"},{"issue":"2","key":"zoi180096r12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1021\/es2038257","article-title":"Polyfluorinated compounds in serum linked to indoor air in office environments.","volume":"46","author":"Fraser","year":"2012","journal-title":"Environ Sci Technol"},{"issue":"9","key":"zoi180096r13","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers.","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ Health Perspect"},{"issue":"1","key":"zoi180096r14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1532-0456(03)00043-7","article-title":"Alterations in cell membrane properties caused by perfluorinated compounds.","volume":"135","author":"Hu","year":"2003","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"4","key":"zoi180096r15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.aquatox.2007.09.009","article-title":"Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes.","volume":"85","author":"Liu","year":"2007","journal-title":"Aquat Toxicol"},{"key":"zoi180096r16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tox.2017.01.012","article-title":"Poly- and perfluorinated compounds activate human pregnane X receptor.","volume":"380","author":"Zhang","year":"2017","journal-title":"Toxicology"},{"issue":"2","key":"zoi180096r17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/toxsci\/kfl014","article-title":"Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-a, -\u00df, and -?, liver X receptor-\u00df, and retinoid X receptor-a.","volume":"92","author":"Vanden Heuvel","year":"2006","journal-title":"Toxicol Sci"},{"issue":"1","key":"zoi180096r18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/toxsci\/kfn166","article-title":"Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths.","volume":"106","author":"Wolf","year":"2008","journal-title":"Toxicol Sci"},{"issue":"1-3","key":"zoi180096r19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tox.2011.06.012","article-title":"Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.","volume":"288","author":"Bjork","year":"2011","journal-title":"Toxicology"},{"issue":"2","key":"zoi180096r20","doi-asserted-by":"publisher","first-page":"e1002502","DOI":"10.1371\/journal.pmed.1002502","article-title":"Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: a prospective study.","volume":"15","author":"Liu","year":"2018","journal-title":"PLoS Med"},{"issue":"2","key":"zoi180096r21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1289\/ehp.0901165","article-title":"Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general US population.","volume":"118","author":"Nelson","year":"2010","journal-title":"Environ Health Perspect"},{"issue":"19","key":"zoi180096r22","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1021\/es100626h","article-title":"Determinants of plasma PFOA and PFOS levels among 652 Danish men.","volume":"45","author":"Eriksen","year":"2011","journal-title":"Environ Sci Technol"},{"issue":"10","key":"zoi180096r23","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2337\/dc16-0269","article-title":"Longitudinal associations of exposure to perfluoroalkylated substances in childhood and adolescence and indicators of adiposity and glucose metabolism 6 and 12 years later: the European Youth Heart Study.","volume":"39","author":"Domazet","year":"2016","journal-title":"Diabetes Care"},{"issue":"4","key":"zoi180096r24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2337\/dc08-1816","article-title":"Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults.","volume":"32","author":"Lin","year":"2009","journal-title":"Diabetes Care"},{"issue":"4","key":"zoi180096r25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2337\/diacare.22.4.623","article-title":"The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes.","volume":"22","author":"Diabetes Prevention Program Research Group","year":"1999","journal-title":"Diabetes Care"},{"issue":"6","key":"zoi180096r26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi180096r27","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","article-title":"The Diabetes Prevention Program (DPP): description of lifestyle intervention.","volume":"25","author":"Diabetes Prevention Program (DPP) Research Group","year":"2002","journal-title":"Diabetes Care"},{"issue":"11","key":"zoi180096r28","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.2337\/diacare.23.11.1619","article-title":"The Diabetes Prevention Program: baseline characteristics of the randomized cohort.","volume":"23","author":"The Diabetes Prevention Program Research Group","year":"2000","journal-title":"Diabetes Care"},{"issue":"9702","key":"zoi180096r29","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"zoi180096r30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2337\/dc11-1468","article-title":"The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP\/DPPOS.","volume":"35","author":"Diabetes Prevention Program Research Group","year":"2012","journal-title":"Diabetes Care"},{"issue":"11","key":"zoi180096r31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"zoi180096r32","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"15","key":"zoi180096r33","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/j.chroma.2010.10.051","article-title":"Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicals.","volume":"1218","author":"Kato","year":"2011","journal-title":"J Chromatogr A"},{"issue":"10","key":"zoi180096r34","doi-asserted-by":"publisher","first-page":"107001","DOI":"10.1289\/EHP1612","article-title":"Plasma concentrations of per- and polyfluoroalkyl substances at baseline and associations with glycemic indicators and diabetes incidence among high-risk adults in the Diabetes Prevention Program Trial.","volume":"125","author":"Cardenas","year":"2017","journal-title":"Environ Health Perspect"},{"issue":"1","key":"zoi180096r35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/1047322X.1990.10389587","article-title":"Estimation of average concentration in the presence of nondetectable values.","volume":"5","author":"Hornung","year":"1990","journal-title":"Appl Occup Environ Hyg"},{"issue":"6","key":"zoi180096r36","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.2337\/db07-0009","article-title":"Body size and shape changes and the risk of diabetes in the diabetes prevention program.","volume":"56","author":"Fujimoto","year":"2007","journal-title":"Diabetes"},{"issue":"5","key":"zoi180096r37","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/ajcn\/87.5.1212","article-title":"Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program.","volume":"87","author":"Bray","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"zoi180096r38","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/oby.2006.246","article-title":"Relationship of body size and shape to the development of diabetes in the diabetes prevention program.","volume":"14","author":"Diabetes Prevention Program Research Group","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"zoi180096r41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4.","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"issue":"4","key":"zoi180096r42","doi-asserted-by":"publisher","first-page":"E608","DOI":"10.1210\/jc.2013-3460","article-title":"Adiposity and glycemic control in children exposed to perfluorinated compounds.","volume":"99","author":"Timmermann","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"zoi180096r43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.envpol.2017.09.019","article-title":"Association among total serum isomers of perfluorinated chemicals, glucose homeostasis, lipid profiles, serum protein and metabolic syndrome in adults: NHANES, 2013-2014.","volume":"232","author":"Liu","year":"2018","journal-title":"Environ Pollut"},{"key":"zoi180096r44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.envres.2012.11.006","article-title":"Do perfluoroalkyl substances affect metabolic function and plasma lipids?\u2014analysis of the 2007-2009, Canadian Health Measures Survey (CHMS) Cycle 1.","volume":"121","author":"Fisher","year":"2013","journal-title":"Environ Res"},{"issue":"6","key":"zoi180096r45","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1210\/en.2005-1129","article-title":"Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.","volume":"147","author":"Gr\u00fcn","year":"2006","journal-title":"Endocrinology"},{"issue":"3","key":"zoi180096r46","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00394-015-0915-0","article-title":"The modifying effect of vitamin C on the association between perfluorinated compounds and insulin resistance in the Korean elderly: a double-blind, randomized, placebo-controlled crossover trial.","volume":"55","author":"Kim","year":"2016","journal-title":"Eur J Nutr"},{"issue":"2","key":"zoi180096r47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0021-9150(03)00018-2","article-title":"Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women.","volume":"167","author":"Elosua","year":"2003","journal-title":"Atherosclerosis"},{"key":"zoi180096r49","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.chemosphere.2017.04.122","article-title":"Substitution of PFAS chemistry in outdoor apparel and the impact on repellency performance.","volume":"181","author":"Hill","year":"2017","journal-title":"Chemosphere"},{"issue":"7","key":"zoi180096r50","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s11356-010-0439-3","article-title":"Polyfluorinated surfactants (PFS) in paper and board coatings for food packaging.","volume":"18","author":"Trier","year":"2011","journal-title":"Environ Sci Pollut Res Int"},{"issue":"3","key":"zoi180096r51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1021\/acs.estlett.6b00435","article-title":"Fluorinated compounds in US fast food packaging.","volume":"4","author":"Schaider","year":"2017","journal-title":"Environ Sci Technol Lett"},{"issue":"13","key":"zoi180096r52","doi-asserted-by":"publisher","first-page":"7496","DOI":"10.1021\/jf104943p","article-title":"Levels of perfluorinated compounds in food and dietary intake of PFOS and PFOA in the Netherlands.","volume":"59","author":"Noorlander","year":"2011","journal-title":"J Agric Food Chem"},{"issue":"3","key":"zoi180096r53","doi-asserted-by":"publisher","first-page":"037001","DOI":"10.1289\/EHP2619","article-title":"Plasma concentrations of perfluoroalkyl substances and risk of type 2 diabetes: a prospective investigation among US women.","volume":"126","author":"Sun","year":"2018","journal-title":"Environ Health Perspect"},{"key":"zoi180096r10","volume-title":"Fluorinated Surfactants and Repellents","author":"Kissa","year":"2001"},{"key":"zoi180096r39","volume-title":"Anthropometric Standardization Reference Manual (Abridged Version)","author":"Lohman","year":"1988"},{"key":"zoi180096r40","volume-title":"National Health and Nutrition Examination Survey: Fourth National Report on Human Exposure to Environmental Chemicals","year":"2018"},{"key":"zoi180096r48","volume-title":"Survey and Environmental\/Health Assessment of Fluorinated Substances in Impregnated Consumer Products and Impregnating Agents","author":"Jensen","year":"2008"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/1\/4\/e181493\/17306836\/cardenas_2018_oi_180096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T01:15:20Z","timestamp":1550711720000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.1493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.1493","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]}}}